Ca 2+ as a Mediator of Ischemic Preconditioning
- 1 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 80 (6) , 790-799
- https://doi.org/10.1161/01.res.80.6.790
Abstract
We tested the hypothesis that elevation of [Ca2+]i during ischemic preconditioning (IPC) stimulates protein kinase C (PKC), which confers the protection against the ischemic injury. Langendorff-perfused rat hearts were subjected to 40-minute global ischemia followed by 30-minute reperfusion (I/R). In preconditioned groups, hearts were subjected to either IPC, consisting of 5-minute global ischemia and 10-minute reperfusion, or high-Ca2+ preconditioning (HCPC), ie, the 5-minute perfusion of higher Ca2+ perfusate (2.3 mmol/L Ca2+) followed by 10-minute perfusion of normal perfusate (1.8 mmol/L Ca2+), and then were subjected to I/R. A significant functional recovery and decreased lactate dehydrogenase release were observed in HCPC and IPC hearts compared with ischemic control hearts. ATP contents of preconditioned hearts were significantly higher than those of the ischemic control hearts. The cell structure in preconditioned hearts was preserved better than that in the ischemic control hearts. Furthermore, the activation and translocation of PKC from cytoplasm to sarcolemma were observed in the preconditioned hearts. Verapamil administered during IPC significantly attenuated the salutary effects of IPC. Administration of chelerythrine, a specific PKC inhibitor, completely abolished the HCPC- and IPC-induced cardioprotection. The translocation of PKC by IPC was blocked by verapamil or chelerythrine. Immunohistochemical study using rabbit polyclonal antibody against PKC isoforms indicated that stress induced by IPC or HCPC evoked the translocation of PKCα and PKCδ to the cell membrane. Translocation of PKC isoforms was attenuated by the treatment with verapamil or chelerythrine. These results demonstrate that (1) a transient increase in [Ca2+]i during IPC is an important trigger for the activation of PKC, which is responsible for cardioprotection; (2) the elevation of [Ca2+]i during IPC, at least partly, resulted from Ca2+ entry via voltage-dependent Ca2+ channel; and (3) activation and translocation of PKCα and PKCδ occur during IPC and HCPC and may be important in preconditioning.Keywords
This publication has 37 references indexed in Scilit:
- Chelerythrine is a potent and specific inhibitor of protein kinase CPublished by Elsevier ,2004
- Ischemic Preconditioning: Bioenergetic and Metabolic Changes and the Role of Endogenous AdenosineJournal of Molecular and Cellular Cardiology, 1996
- Signal Transduction by the Phosphatidylinositol Cycle in MyocardiumJournal of Molecular and Cellular Cardiology, 1995
- Calcium and the Endothelin-1 and α1-Adrenergic Stimulated Phosphatidylinositol Cycle in Cultured Rat CardiomyocytesJournal of Molecular and Cellular Cardiology, 1994
- Role of adenosine and its interaction with adrenoceptor activity in ischaemic and reperfusion injury of the myocardiumCardiovascular Research, 1993
- Intracellular calcium and ventricular function. Effects of nisoldipine on global ischemia in the isovolumic, coronary-perfused heart.Journal of Clinical Investigation, 1992
- Myocardial stunning: a role for calcium antagonists during ischaemia?Cardiovascular Research, 1992
- Activation of the β1 isozyme of phospholipase C by α subunits of the Gq class of G proteinsNature, 1991
- Subcellular distribution and immunocytochemical localization of protein kinase C in myocardium, and phosphorylation of troponin in isolated myocytes stimulated by isoproterenol or phorbol esterBiochemical and Biophysical Research Communications, 1989
- Development of a convenient spectrophotometric assay for peptide phosphorylation catalyzed by adenosine 3',5'-monophosphate dependent protein kinaseJournal of the American Chemical Society, 1980